Multiple sclerosis study collecting health data and samples
Part of Brain & nervous system, Immune system & allergy clinical trials.
This study collects health information and samples from people with multiple sclerosis (MS) in different stages to help develop better tools for managing the disease. By participating, you could help researchers use data science to improve MS care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years old or older
- Have a confirmed diagnosis of multiple sclerosis (MS)
- Your MS is either in the early stages (diagnosed within the last 3 years), or you are being evaluated for a change in treatment, or you are transitioning to a progressive form of MS
- Be fluent in French, English, or German
- Not be pregnant at the start of the study
- Be willing to attend study visits, give samples, and answer questionnaires
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how multiple sclerosis (MS) affects your thinking, sleep, and tiredness. It compares people with MS who have at least mild fatigue to people without MS who also have sleep problems, to understand these issues better.
This study follows people with multiple sclerosis over time using a smartphone app and clinic visits. It aims to better understand the disease and improve care.
This study looks at different immune cells in blood and, sometimes, spinal fluid (CSF) to understand what’s driving multiple sclerosis (MS) or early MS-like symptoms. Your participation may help researchers better explain the disease and potentially improve how it’s diagnosed or treated.
This trial uses brain MRI and eye imaging tests to study research markers in people with multiple sclerosis (MS) and related neurologic conditions. It may help researchers better understand these diseases and how they change over time.
This study looks at whether MS relapses happen without any signs of new disease activity on an MRI scan. By tracking your symptoms and scans, researchers hope to better understand how MS affects people in real life. If you qualify, you may help improve future treatment decisions.
This study follows people with multiple sclerosis over time to learn more about the disease and improve care. If you join, you will help researchers understand MS better, which could lead to better treatments.
Hear when a new Multiple Sclerosis, Relapsing-Remitting trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.